American Society of Hirudotherapy

Using an unconventional perfusion pattern in ear replantation-arterialization of the venous system

Momeni A, Parrett BM, Kuri M (2014) · Microsurgery · 1 patient

Case-level evidence: FDA has cleared Hirudo medicinalis as a medical device (K040187, June 21 2004) for venous congestion in surgical flaps. Other uses are off-label or investigational.Study record: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.

Study Profile

Design
single-patient case report (25-year-old male, human bite injury, Stanford University Medical Center)
Patient
1
Presentation and intervention
Subtotal ear replantation with end-to-end arterio-venous anastomosis (arterialization of venous system) without vein grafts; postoperative leech therapy for venous drainage
Outcome
Successful ear survival with arterialization of venous system; postoperative leech therapy provided venous drainage; discharged after 14 days; reportedly first case of subtotal ear amputation successfully replanted by arterialization of venous system
Follow-up duration
Postoperative discharge at 14 days

Key Findings

  • First reported successful ear replant via venous system arterialization
  • End-to-end arterio-venous anastomosis without vein grafts
  • Postoperative leech therapy enabled unconventional perfusion
  • 14-day hospitalization to discharge
  • Preserves superficial temporal vessels for future use

Limitations

  • Single case - hypothesis-generating only
  • Cannot generalize unconventional approach
  • Limited long-term aesthetic data
  • Patient selection criteria for venous arterialization unclear
  • Human bite mechanism may limit comparison to other amputations

Clinical Implications

Momeni 2014 demonstrates how reliable leech-mediated venous drainage support enables surgical innovation - specifically, unconventional venous system arterialization in ear replantation. For US clinicians under K040187, this case illustrates the device's enabling role for technical innovation in challenging anatomic scenarios where conventional vein grafting is not feasible.

Related studies

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.